Half Abandon Metformin Within a Year of Diabetes
Diagnosis (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 3, 2021 Category: General Medicine Source Type: news

Costs of raw material for drugs rise by up to 140%
API prices of certain drugs like fever and pain relief drug paracetamol and life-saving antibiotic Meropenem (also used for Covid), and anti-diabetic metformin, have more than doubled to as high as 139%, 127% and 124% respectively, putting the spotlight back on India ’s near total-dependence on the Dragon. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2021 Category: Pharmaceuticals Source Type: news

Metformin Use May Curb BCC Risk Metformin Use May Curb BCC Risk
The decrease in basal cell carcinoma (BCC) risk was seen across all metformin dosing levels, but the reason for this remains unclear.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 15, 2021 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

After Metformin, Which Drug Makes the GRADE? After Metformin, Which Drug Makes the GRADE?
Which medication should be added after metformin? The GRADE study attempts to fill the evidence gap.Medscape Diabetes & Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 9, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news

Cadila Healthcare arm recalls 21,240 bottles of diabetes drug in US
Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 4, 2021 Category: Pharmaceuticals Source Type: news

Synjardy XR (empagliflozin and metformin extended-release)
Title: Synjardy XR (empagliflozin and metformin extended-release)Category: MedicationsCreated: 7/2/2021 12:00:00 AMLast Editorial Review: 7/2/2021 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - July 2, 2021 Category: Endocrinology Source Type: news

What's Best for Diabetes After Metformin? GRADE Outdated at Outset What's Best for Diabetes After Metformin? GRADE Outdated at Outset
The GRADE trial compared four different agents as add-ons to metformin for type 2 diabetes, and while liraglutide and insulin glargine fared best, the study is already outdated, said one commentator.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 30, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

SGLT2 Inhibitor Better Second-Line Diabetes Pick Than Sulfonylurea When Cost Is Not an Issue SGLT2 Inhibitor Better Second-Line Diabetes Pick Than Sulfonylurea When Cost Is Not an Issue
When metformin fails to sufficiently lower blood glucose levels, it ' s better to add an SGLT2 inhibitor rather than a sulfonylurea, according to a comparative effectiveness analysis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 30, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Synjardy (empagliflozin and metformin)
Title: Synjardy (empagliflozin and metformin)Category: MedicationsCreated: 6/30/2021 12:00:00 AMLast Editorial Review: 6/30/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 30, 2021 Category: Drugs & Pharmacology Source Type: news

Best Blood Sugar Meds for Type 2 Diabetes
Taking metformin for type 2 diabetes but still having trouble controlling your blood sugar? New research reveals which drugs may be most helpful. (Source: WebMD Health)
Source: WebMD Health - June 30, 2021 Category: Consumer Health News Source Type: news

Which Blood Sugar Meds Work Best Against Type 2 Diabetes?
TUESDAY, June 29, 2021 -- You have type 2 diabetes, and you are already taking an old standby drug, metformin. But you still need help controlling your blood sugar levels. Which medication would be the best? New research pitted several diabetes... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 29, 2021 Category: General Medicine Source Type: news

' Stunning' Twincretin Beats Semaglutide in Type 2 Diabetes'Stunning' Twincretin Beats Semaglutide in Type 2 Diabetes
Head-to-head pivotal trial results show weekly tirzepatide injections surpassed 1 mg semaglutide weekly for A1c reduction and weight loss as second-line therapy after metformin in type 2 diabetes.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 27, 2021 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Discontinuing Metformin: The Crowdsourced View Discontinuing Metformin: The Crowdsourced View
Readers were divided on the decision to stop an elderly woman ' s metformin and reduce her pill burden.Medscape Family Medicine (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 23, 2021 Category: Primary Care Tags: Family Medicine/Primary Care Article Source Type: news

FDA Recalls More Metformin Extended-Release Tablets FDA Recalls More Metformin Extended-Release Tablets
Two lots of metformin HCl extended-release tablets have been recalled by Viona Pharmaceuticals because unacceptable levels of nitrosodimethylamine, a likely carcinogen, were found in the 750-mg tablets.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 15, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Viona Pharmaceuticals Inc., is voluntarily recalling 2 (two) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news